Home Healthcare Healthcare Services Nucleic Acid Therapeutics CDMO Market

Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Cell & Gene Therapies, RNA-based Therapies, mRNA Therapies, siRNA Therapies, Others), By Service (Process Development & Optimization Services, Manufacturing Services, Analytical & Quality Control Services, Others), By End Use (Pharmaceutical & Biotechnology Companies, Government & Academic Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 30, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR4354DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Nucleic Acid Therapeutics CDMO Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Cell & Gene Therapies
    2. RNA-based Therapies
    3. mRNA Therapies
    4. siRNA Therapies
    5. Others
  2. Nucleic Acid Therapeutics CDMO Market, By Service 2022-2034 (USD MILLION/ Units)
    1. Process Development & Optimization Services
    2. Manufacturing Services
    3. Analytical & Quality Control Services
    4. Others
  3. Nucleic Acid Therapeutics CDMO Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical & Biotechnology Companies
    2. Government & Academic Research Institutes
  4. Regional Nucleic Acid Therapeutics CDMO Market
    1. North America
      1. North America Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      2. North America Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      3. North America Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
      4. U.S. Nucleic Acid Therapeutics CDMO Market
        1. U.S. Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. U.S. Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. U.S. Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      5. Canada Nucleic Acid Therapeutics CDMO Market
        1. Canada Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Canada Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Canada Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
    2. Europe
      1. Europe Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      2. Europe Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      3. Europe Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
      4. U.K. Nucleic Acid Therapeutics CDMO Market
        1. U.K. Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. U.K. Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. U.K. Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      5. Germany Nucleic Acid Therapeutics CDMO Market
        1. Germany Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Germany Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Germany Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      6. France Nucleic Acid Therapeutics CDMO Market
        1. France Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. France Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. France Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      7. Spain Nucleic Acid Therapeutics CDMO Market
        1. Spain Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Spain Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Spain Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      8. Italy Nucleic Acid Therapeutics CDMO Market
        1. Italy Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Italy Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Italy Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      9. Russia Nucleic Acid Therapeutics CDMO Market
        1. Russia Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Russia Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Russia Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      10. Nordic Nucleic Acid Therapeutics CDMO Market
        1. Nordic Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Nordic Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Nordic Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      11. Benelux Nucleic Acid Therapeutics CDMO Market
        1. Benelux Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Benelux Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Benelux Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      12. Rest of Europe Nucleic Acid Therapeutics CDMO Market
        1. Rest of Europe Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Rest of Europe Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Rest of Europe Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
    3. APAC
      1. APAC Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      2. APAC Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      3. APAC Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
      4. China Nucleic Acid Therapeutics CDMO Market
        1. China Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. China Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. China Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      5. Korea Nucleic Acid Therapeutics CDMO Market
        1. Korea Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Korea Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Korea Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      6. Japan Nucleic Acid Therapeutics CDMO Market
        1. Japan Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Japan Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Japan Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      7. India Nucleic Acid Therapeutics CDMO Market
        1. India Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. India Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. India Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      8. Australia Nucleic Acid Therapeutics CDMO Market
        1. Australia Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Australia Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Australia Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      9. Taiwan Nucleic Acid Therapeutics CDMO Market
        1. Taiwan Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Taiwan Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Taiwan Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      10. South East Asia Nucleic Acid Therapeutics CDMO Market
        1. South East Asia Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. South East Asia Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. South East Asia Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      11. Rest of Asia-Pacific Nucleic Acid Therapeutics CDMO Market
        1. Rest of Asia-Pacific Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Rest of Asia-Pacific Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Rest of Asia-Pacific Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
    4. Middle East and Africa
      1. Middle East and Africa Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      2. Middle East and Africa Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      3. Middle East and Africa Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
      4. UAE Nucleic Acid Therapeutics CDMO Market
        1. UAE Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. UAE Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. UAE Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      5. Turkey Nucleic Acid Therapeutics CDMO Market
        1. Turkey Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Turkey Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Turkey Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      6. Saudi Arabia Nucleic Acid Therapeutics CDMO Market
        1. Saudi Arabia Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Saudi Arabia Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Saudi Arabia Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      7. South Africa Nucleic Acid Therapeutics CDMO Market
        1. South Africa Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. South Africa Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. South Africa Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      8. Egypt Nucleic Acid Therapeutics CDMO Market
        1. Egypt Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Egypt Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Egypt Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      9. Nigeria Nucleic Acid Therapeutics CDMO Market
        1. Nigeria Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Nigeria Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Nigeria Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      10. Rest of MEA Nucleic Acid Therapeutics CDMO Market
        1. Rest of MEA Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Rest of MEA Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Rest of MEA Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
    5. LATAM
      1. LATAM Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      2. LATAM Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      3. LATAM Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
      4. Brazil Nucleic Acid Therapeutics CDMO Market
        1. Brazil Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Brazil Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Brazil Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      5. Mexico Nucleic Acid Therapeutics CDMO Market
        1. Mexico Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Mexico Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Mexico Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      6. Argentina Nucleic Acid Therapeutics CDMO Market
        1. Argentina Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Argentina Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Argentina Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      7. Chile Nucleic Acid Therapeutics CDMO Market
        1. Chile Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Chile Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Chile Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      8. Colombia Nucleic Acid Therapeutics CDMO Market
        1. Colombia Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Colombia Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Colombia Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
      9. Rest of LATAM Nucleic Acid Therapeutics CDMO Market
        1. Rest of LATAM Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell & Gene Therapies
          2. RNA-based Therapies
          3. mRNA Therapies
          4. siRNA Therapies
          5. Others
        2. Rest of LATAM Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
          1. Process Development & Optimization Services
          2. Manufacturing Services
          3. Analytical & Quality Control Services
          4. Others
        3. Rest of LATAM Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Government & Academic Research Institutes
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.